Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Hyaluronate and Bicarbonate for FBSS Prevention
NCT06999993Phase 3Active, not recruiting
- Sponsor
- Misr University for Science and Technology
- Start
- Jun 2025
- Primary completion
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of sodium hyaluronate in epidural fibrosis, failed back surgery syndrome (FBSS), sponsored by Misr University for Science and Technology. Started Jun 2025; status: active, not recruiting.
02
Drugs
sodium hyaluronate
03
Conditions
epidural fibrosisfailed back surgery syndrome (FBSS)
Beyond the preview
Go deeper on NCT06999993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999993.